Skip to main content
. 2023 Apr 29;129(1):38–45. doi: 10.1038/s41416-023-02279-x

Fig. 1. SRA737 monotherapy study enrolment by dose level.

Fig. 1

Patient numbers and tumour types enrolled in different cohorts in dose escalation and expansion phases of the study.